Pi-Cardia today announced the first commercial procedures with its ShortCut leaflet modification device for enabling heart ...

In patients undergoing transcatheter aortic valve implantation (TAVI) for severe aortic stenosis (AS) with stable coronary ...

Pi-Cardia Inc., a global leader in the development of leaflet modification solutions for treating heart valves, announced today the first commercial procedures with ShortCut™ - the world's first ...

Discover how recent advancements in cardiovascular medicine, including TAVI and TEER, are revolutionizing heart disease ...

000th TAVR (Transcatheter Aortic Valve Replacement) procedure. This achievement is more than a number – it represents improved quality of life for patients who have aortic valve stenosis.

Philips and Medtronic partner to upskill 300+clinicians in structural heart imaging in India: Our Bureau, Bengaluru Monday, March 3, 2025, 12:45 Hrs [IST] Philips, a leader in hea ...

Minimally invasive heart procedures like transcatheter aortic valve replacement (TAVR) and MitraClip placement to treat mitral regurgitation can improve quality of life, and even be lifesaving, for ...

Transcatheter aortic valve implantation is currently reserved for patients considered as high risk for conventional surgery, most often through advanced age and excessive comorbidity. However ...

First dedicated leaflet modification solution to enable TAVR in patients at risk of coronary obstruction Pi-Cardia Inc., a global leader in the development of leaflet modification solutions for treati ...